<i>FBXW7</i> and <i>NOTCH1</i> mutations in childhood T cell acute lymphoblastic leukaemia and T cell non‐Hodgkin lymphomaHyuntae Park, Yasuhide Hayashi, Keiko Yumura‐Yagi et al.|British Journal of Haematology|2009Cited by 120
A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trialDaisuke Tomizawa, Katsuyoshi Koh, Takako Miyamura et al.|Blood|2020Cited by 102
Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in JapanTakashi Taga, Souichi Adachi, Tomoyuki Watanabe et al.|Pediatric Blood & Cancer|2015Cited by 48
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemiaH. Matsuo, Souichi Adachi, Mikio Kajihara et al.|Haematologica|2014Cited by 42
Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study GroupH. Matsuo, Souichi Adachi, M Kajihara et al.|Blood Cancer Journal|2014Cited by 32